STIM1 and neuroblastoma: Most importantly, this study demonstrated that in SH-SY5Y neuroblastoma cells, MPP+ treatment decreased TRPC1 expression, TRPC1 interaction with the SOCE modulator stromal interaction molecule 1 (STIM1), and Ca2+ entry into the cells.